Noom announced the appointment of former Match Group CEO Mandy Ginsberg to its board as an independent director and that Dr. Linda Anegawa has been hired as Noom’s first-ever Medical Director.
Since its founding in 2008, Noom has established itself as the leading digital health platform, harnessing behavior change and technology to create long-term positive health outcomes. Its psychology-based and science-backed approach has helped millions of people live healthier lives.
Ginsberg joins Noom as an independent director and will be an essential advisor to the company as it continues to innovate its platform and scales to reach new users. She is a renowned business leader with deep expertise in consumer technology, subscription monetization, and consumer marketing, and as Match Group CEO was responsible for a portfolio of industry-leading brands including Tinder, Match, and Hinge where she drove unprecedented growth. She currently serves on the boards of Uber Technologies and thredUP and is an operating partner at Advent International.
Also Read: PsychoGenics Launches eCube, a New AI-Enabled Platform for Drug Discovery
“I have seen firsthand how technology provides powerful and innovative solutions that positively impacts the lives of consumers,” said Ginsberg. “During the pandemic, my friends and I used Noom and were blown away by its efficacy and how much we were learning about our health. In the dating space, I watched how digital innovation can help positively change people’s lives by introducing them to people they wouldn’t have met otherwise. Given its first-of-its-kind programs, Noom has the ability to transform people’s lives as well. I am thrilled to be on this journey with the team.”
Dr. Anegawa, MD, FACP, Dipl. ABOM, is a double-board certified physician in both internal medicine and obesity medicine. She brings over 20 years of expertise in academic medicine, digital health leadership, and obesity care to her role as Noom’s Medical Director. In her new role, Anegawa is responsible for overseeing Noom’s clinical mission and the expansion of Noom’s behavior change platform to include treatment of a broad range of chronic metabolic diseases alongside Noom’s Chief of Psychology and behavioral science team.
“Noom offers a holistic solution to users that allows them to see the interconnectivity of the various biological and psychological factors that contribute to a person’s overall health,” said Anegawa. “I’ve yet to see another health platform take such a comprehensive and integrated approach to consumer-driven healthcare and believe there is limitless potential as we continue to introduce science-backed programs that will treat the roots of chronic diseases.”
SOURCE: Businesswire